Heart Failure (HF) Clinical Trial
Official title:
Systematic Withdrawal of Neurohumoral Blocker Therapy in Optimally Responding Patients to Cardiac Resynchronization Therapy: the STOP-CRT Trial
The primary objective of this study is to demonstrate that in patients with recuperated/normalized left ventricular function, defined as an ejection fraction (EF) ≥ 50%, after implantation of cardiac resynchronization therapy, device treatment is sufficient and neurohumoral blocker therapy can safely be withdrawn
n/a
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT03456856 -
A Study of Ivabradine in African-American/ Black Subjects With Heart Failure and Left Ventricular Systolic Dysfunction.
|
Phase 4 | |
| Completed |
NCT03901729 -
A Trial to Study BAY1753011 in Patients With Congestive Heart Failure
|
Phase 2 | |
| Completed |
NCT02301689 -
SchlaHF-XT-Register. Sleep Disordered Breathing in Heart Failure Register
|
||
| Completed |
NCT04915118 -
A Study Called NATION-OS to Learn About the Link Between N-terminal proBNP (NT-proBNP) Levels and Medical Problems Due to Heart Failure (HF) in German Patients With HF
|
||
| Recruiting |
NCT04149743 -
HEMOTAG® Assessment for Short-term Outcomes of Heart Failure
|
N/A | |
| Recruiting |
NCT05652218 -
REsynchronization Comparison In LBBB and Normal or Mildly Reduced VENTricular Function With CRT (REINVENT-CRT)
|
N/A | |
| Completed |
NCT01936649 -
Open-label, Test-retest Study Assessing Reproducibility of Quantitative Measurements of Myocardial Uptake of AdreView.
|
Phase 4 | |
| Completed |
NCT02127307 -
Phase 4 Study to Demonstrate Prognostic Usefulness of AdreView™ Scintigraphy for Identifying Subjects With Heart Failure Who Will Experience Death During 60 Months Follow-up.
|
N/A |